Stay updated on Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Sign up to get notified when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.

Latest updates to the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page
- Check2 days agoChange DetectedNo additions or deletions of note were detected on the Study Details page for NCT00954460; the content and layout remain consistent with the trial information.SummaryDifference0.2% 
- Check9 days agoNo Change Detected
- Check24 days agoChange Detected- Added a government status notice and operating details, plus a link to official operating-status sources. - Updated version to v3.2.0 and removed the old v3.1.0 tag.SummaryDifference4% 
- Check32 days agoChange DetectedUpdate: revision from v3.0.2 to v3.1.0.SummaryDifference0.1% 
- Check47 days agoChange DetectedUpdated revision to v3.0.2 and removed the Back to Top element. No core content, pricing, stock, or time-slot information was affected.SummaryDifference0.3% 
- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.3% 
- Check61 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as detailed information on Gaucher disease and related enzymes, while removing previous references to specific locations and certain disease types.SummaryDifference3% 
Stay in the know with updates to Velaglucerase Alfa for Type 1 Gaucher Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Velaglucerase Alfa for Type 1 Gaucher Clinical Trial page.